Search hospitals > Nebraska > Grand Island
Nebraska Cancer Specialists
Claim this profileGrand Island, Nebraska 68803
Conducts research for Follicular Lymphoma
Conducts research for Marginal Zone Lymphoma
Conducts research for MALT Lymphoma
Conducts research for Breast Cancer
Conducts research for Chronic Lymphocytic Leukemia
7 reported clinical trials
3 medical researchers
Summary
Nebraska Cancer Specialists is a medical facility located in Grand Island, Nebraska. This center is recognized for care of Follicular Lymphoma, Marginal Zone Lymphoma, MALT Lymphoma, Breast Cancer, Chronic Lymphocytic Leukemia and other specialties. Nebraska Cancer Specialists is involved with conducting 7 clinical trials across 30 conditions. There are 3 research doctors associated with this hospital, such as Ralph Hauke, MD, Margaret Block, M.D., and David Crockett, MD.Top PIs
Ralph Hauke, MDNebraska Cancer Specialists2 years of reported clinical research
Expert in Prostate Cancer
Studies Lung Cancer
36 reported clinical trials
74 drugs studied
Margaret Block, M.D.Nebraska Cancer Specialists4 years of reported clinical research
Studies Breast Cancer
Studies Pancreatic Cancer
6 reported clinical trials
11 drugs studied
David Crockett, MDNebraska Cancer Specialists3 years of reported clinical research
Studies Cancer
Studies Solid Tumors
1 reported clinical trial
1 drug studied
Clinical Trials running at Nebraska Cancer Specialists
Follicular Lymphoma
Marginal Zone Lymphoma
MALT Lymphoma
Breast Cancer
Chronic Lymphocytic Leukemia
Non-Hodgkin's Lymphoma
Mantle Cell Lymphoma
Small Cell Lung Cancer
Mixed-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Zanubrutinib + Anti-CD20
for Lymphoma
The purpose of the study is to compare the efficacy of zanubrutinib plus obinutuzumab versus lenalidomide plus rituximab (R\^2) in participants with relapsed/refractory (R/R) follicular lymphoma (FL), as measured by progression-free survival as determined by an independent review committee in accordance with the 2014 modification of the International Working Group on non-Hodgkin lymphoma (NHL) Criteria based on n positron emission tomography and computed tomography (PET/CT), and to compare the efficacy of zanubrutinib plus rituximab versus R\^2 in participants with R/R marginal zone lymphoma (MZL), as measured by progression free survival (PFS) assessed by IRC in accordance with CT-based Lugano 2014 Criteria.
Recruiting2 awards Phase 35 criteria
BGB-16673
for B-Cell Cancers
This trial tests a new drug called BGB-16673 to find the best dose for patients. It aims to determine how well the drug works and its safety. The study involves finding the right dose and expanding testing to more patients.
Recruiting1 award Phase 1 & 25 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Nebraska Cancer Specialists?
Nebraska Cancer Specialists is a medical facility located in Grand Island, Nebraska. This center is recognized for care of Follicular Lymphoma, Marginal Zone Lymphoma, MALT Lymphoma, Breast Cancer, Chronic Lymphocytic Leukemia and other specialties. Nebraska Cancer Specialists is involved with conducting 7 clinical trials across 30 conditions. There are 3 research doctors associated with this hospital, such as Ralph Hauke, MD, Margaret Block, M.D., and David Crockett, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.